Cardiovascular Drugs and Therapy

, Volume 24, Issue 1, pp 71–75

Functional Assessment of HDL: Moving Beyond Static Measures for Risk Assessment


DOI: 10.1007/s10557-009-6214-3

Cite this article as:
Rosenson, R.S. Cardiovasc Drugs Ther (2010) 24: 71. doi:10.1007/s10557-009-6214-3

Key words

High density lipoproteinCholesterol ester transfer proteinCholesterol ester transfer protein inhibitorsDalcetrapibTorcetrapibNiacinCardiovascular disease

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.SUNY DownstateBrooklynUSA